Exosome-Derived miR-130a Activates Angiogenesis in Gastric Cancer by Targeting C-MYB in Vascular Endothelial Cells.

[1]  Chuanjiang He,et al.  Exosome Theranostics: Biology and Translational Medicine , 2018, Theranostics.

[2]  A. Popel,et al.  Gene delivery nanoparticles to modulate angiogenesis☆ , 2017, Advanced drug delivery reviews.

[3]  Joseph C. Wu,et al.  Comparison of Non‐Coding RNAs in Exosomes and Functional Efficacy of Human Embryonic Stem Cell‐ versus Induced Pluripotent Stem Cell‐Derived Cardiomyocytes , 2017, Stem cells.

[4]  M. Fabbri,et al.  Cancer-derived exosomic microRNAs shape the immune system within the tumor microenvironment: State of the art. , 2017, Seminars in cell & developmental biology.

[5]  Bruno Larrivée,et al.  Tumor angiogenesis and vascular normalization: alternative therapeutic targets , 2017, Angiogenesis.

[6]  G. Vassalli,et al.  Exosomes: Therapy delivery tools and biomarkers of diseases , 2017, Pharmacology & therapeutics.

[7]  R. Kalluri,et al.  An evolving function of DNA-containing exosomes in chemotherapy-induced immune response , 2017, Cell Research.

[8]  He-da Zhang,et al.  The role of miR-130a in cancer , 2017, Breast Cancer.

[9]  B. Wu,et al.  Protein content and functional characteristics of serum‐purified exosomes from patients with colorectal cancer revealed by quantitative proteomics , 2017, International journal of cancer.

[10]  Megan Cully.  Cancer: Tumour vessel normalization takes centre stage , 2017, Nature Reviews Drug Discovery.

[11]  N. Saba,et al.  Ibrutinib downregulates a subset of miRNA leading to upregulation of tumor suppressors and inhibition of cell proliferation in chronic lymphocytic leukemia , 2017, Leukemia.

[12]  K. Haustermans,et al.  Gastric cancer , 2016, The Lancet.

[13]  George A Calin,et al.  miRNA Deregulation in Cancer Cells and the Tumor Microenvironment. , 2016, Cancer discovery.

[14]  Y. Tomari,et al.  The Functions of MicroRNAs: mRNA Decay and Translational Repression. , 2015, Trends in cell biology.

[15]  G. Rutter,et al.  Role of microRNAs in the age-associated decline of pancreatic beta cell function in rat islets , 2015, Diabetologia.

[16]  Lijun Wu,et al.  Exosomes in cancer: small particle, big player , 2015, Journal of Hematology & Oncology.

[17]  Christian Pilarsky,et al.  Glypican-1 identifies cancer exosomes and detects early pancreatic cancer , 2015, Nature.

[18]  B. Zetter,et al.  The Contribution of Angiogenesis to the Process of Metastasis. , 2015, Cancer journal.

[19]  Victor R. Ambros,et al.  Caenorhabditis elegans microRNAs of the let-7 family act in innate immune response circuits and confer robust developmental timing against pathogen stress , 2015, Proceedings of the National Academy of Sciences.

[20]  Helena Carreira,et al.  Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2) , 2015, The Lancet.

[21]  S. Kourembanas.  Exosomes: vehicles of intercellular signaling, biomarkers, and vectors of cell therapy. , 2015, Annual review of physiology.

[22]  Jane Y. Wu,et al.  CD146 acts as a novel receptor for netrin-1 in promoting angiogenesis and vascular development , 2015, Cell Research.

[23]  B. Qiu,et al.  MicroRNA‐103a inhibits gastric cancer cell proliferation, migration and invasion by targeting c‐Myb , 2015, Cell proliferation.

[24]  Junfeng Zhang,et al.  Investigation of microRNA expression in human serum during the aging process. , 2015, The journals of gerontology. Series A, Biological sciences and medical sciences.

[25]  S. Lawler,et al.  MicroRNAs in cancer: biomarkers, functions and therapy. , 2014, Trends in molecular medicine.

[26]  F. Ciardiello,et al.  Treatment of gastric cancer. , 2014, World journal of gastroenterology.

[27]  X. Chen,et al.  Microvesicle-mediated Transfer of MicroRNA-150 from Monocytes to Endothelial Cells Promotes Angiogenesis* , 2013, The Journal of Biological Chemistry.

[28]  W. Grizzle,et al.  Exosomes are endogenous nanoparticles that can deliver biological information between cells. , 2013, Advanced drug delivery reviews.

[29]  S. Niclou,et al.  EGFR wild-type amplification and activation promote invasion and development of glioblastoma independent of angiogenesis , 2013, Acta Neuropathologica.

[30]  Vincent W. Li,et al.  Cancer prevention by targeting angiogenesis , 2012, Nature Reviews Clinical Oncology.

[31]  M. Masařík,et al.  c-Myb regulates matrix metalloproteinases 1/9, and cathepsin D: implications for matrix-dependent breast cancer cell invasion and metastasis , 2012, Molecular Cancer.

[32]  Alan M Gewirtz,et al.  The c-myb proto-oncogene and microRNA-15a comprise an active autoregulatory feedback loop in human hematopoietic cells. , 2009, Blood.

[33]  Katherine M Malinda,et al.  In vivo matrigel migration and angiogenesis assay. , 2009, Methods in molecular biology.

[34]  D. Gorski,et al.  Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5. , 2008, Blood.

[35]  J. Lötvall,et al.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.

[36]  R. Auerbach,et al.  The sponge/Matrigel angiogenesis assay , 2004, Angiogenesis.

[37]  L. Benjamin,et al.  Angiogenesis: Tumorigenesis and the angiogenic switch , 2003, Nature Reviews Cancer.

[38]  T. Gonda,et al.  Targeting c-Myb expression in human disease , 2003, Expert opinion on therapeutic targets.

[39]  K. M. Malinda.  In vivo matrigel migration and angiogenesis assays. , 2001, Methods in molecular medicine.

[40]  J FusterObregón,et al.  Treatment of gastric cancer , 1999 .

[41]  Michael Schwenk,et al.  Tumor , 1828, The London medical and physical journal.